Cargando…
miR‐200a/b/‐429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
Many patients with locally advanced cervical cancer experience recurrence within the radiation field after chemoradiotherapy. Biomarkers of tumor radioresistance are required to identify patients in need of intensified treatment. Here, the biomarker potential of miR‐200 family members was investigat...
Autores principales: | Nilsen, Anja, Hillestad, Tiril, Skingen, Vilde E., Aarnes, Eva‐Katrine, Fjeldbo, Christina S., Hompland, Tord, Evensen, Tina Sandø, Stokke, Trond, Kristensen, Gunnar B., Grallert, Beata, Lyng, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936520/ https://www.ncbi.nlm.nih.gov/pubmed/35064630 http://dx.doi.org/10.1002/1878-0261.13184 |
Ejemplares similares
-
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
por: Fjeldbo, Christina S., et al.
Publicado: (2020) -
A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
por: Salberg, Unn Beate, et al.
Publicado: (2022) -
Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients
por: Fjeldbo, Christina S., et al.
Publicado: (2016) -
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
por: Hompland, Tord, et al.
Publicado: (2021) -
Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer()
por: Jonsson, Marte, et al.
Publicado: (2019)